Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer,inbladder cancer cell lines: Relationship to KAI1/CD82 levels and invasive behaviour

Oncology Reports

Volumn 16, Issue 6, 2006, Pages 1267-1272

  Rowe, Alexandra ^a,b   Jackson, Paul ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cytoskeleton; KAI1 CD82; KITENIN; Metastasis

Indexed keywords

CARRIER PROTEIN; CD82 ANTIGEN; KAI1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; VANGL1 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; CANCER INVASION; COMPARATIVE STUDY; FLUORESCENCE MICROSCOPY; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE, TUMOR; HUMANS; KANGAI-1 PROTEIN; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; URINARY BLADDER NEOPLASMS;

EID: 39049186574     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.6.1267     Document Type: Article

References (25)

1. Jackson P, Marreiros A and Russell PJ: KAI1 tetraspanin and metastasis suppressor. Int J Biochem Cell Biol 37: 530-534, 2005. (Pubitemid 40022929)
2. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268: 884-886, 1995.
3. Rubinstein E, Naour FL, Laguadriere-Gesbert C, Billard M, Conjeaud H and Boucheix C: CD9, CD63, CD81 and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA antigens. Eur J Immunol 26: 2657-2665, 1996. (Pubitemid 26364842)
4. Takaoka A, Hinoda Y, Satoh S, Adachi Y, Itoh F, Adachi M, and Imai K: Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 16: 1443-1453, 1998. (Pubitemid 28151851)
5. Yang JL, Jackson P, Yu Y, Yoshie O, Ham JM, Russell PJ and Crowe PJ: Invasion and metastasis correlate with down-regulation of KAI1 expression in human colon cancer cell lines. GI Cancer 3: 313-322, 2001. (Pubitemid 34059345)
6. Yang XH, Wei LL, Tang C, Slack R, Mueller S and Lippman ME: Over-expression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 61: 5284-5288, 2001. (Pubitemid 32681565)
7. Jee B, Jin K, Han JH, Song HG and Lee H: Metastasissuppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through a Src-dependent pathway. Exp Mol Med 35: 30-37, 2003. (Pubitemid 36336926)
8. Lee JH, Park SR, Chay KO, et al: KAI1 COOH-Terminal interacting Tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 64: 4235-4243, 2004. (Pubitemid 38802428)
9. Lee JH, Seo YW, Park SR, Kim YJ and Kim KK: Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res 63: 7247-7255, 2003. (Pubitemid 37413464)
10. Lee JH, Cho ES, Kim MY, et al: Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein. Cancer Res 65: 8993-9003, 2005. (Pubitemid 41377391)
11. Jackson P, Grimm MO, Kingsley EA, Brosius U, Antalis T, Yardley G and Russell PJ: Relationship between expression of KAI1 metastasis suppressor gene mRNA and p53 in bladder and prostate cancer cell lines. Urol Oncol 7: 99-104, 2002.
12. Jackson P, Kingsley EA and Russell PJ: Inverse correlation between KAI1 mRNA levels and cell behaviour in bladder cancer cell lines. Cancer Lett 156: 9-17, 2000. (Pubitemid 30326762)
13. Christian BJ, Loretz LJ, Oberley TD and Reznikoff CA: Characterisation of human uro-epithelial cells immortalised in vitro by Simian Virus 40. Cancer Res 47: 6066-6073, 1987. (Pubitemid 18018755)
14. Bubenik J, Baresova J, Viklicky V, Jacoubkova J, Sainerova H and Donner J: Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer 11: 765-773, 1973.
15. Fogh J, Fogh JM and Orfeo T: One hundred and twenty-seven cultured human tumour cell lines producing tumours in nude mice. J Natl Cancer Inst 59: 221-226, 1977. (Pubitemid 8144854)
16. O'Toole C, Price ZH, Ohnuki Y and Unsgaard B: Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 38: 64-76, 1978. (Pubitemid 8397082)
17. Russell PJ, Wass J, Lukeis R, et al: Characterisation of cell lines derived from a multiply aneuploid human bladder transitionalcell carcinoma, UCRU-BL-13. Int J Cancer 44: 276-285, 1989. (Pubitemid 19217215)
18. Russell PJ, Palavidis Z, Rozinova E, et al: Characterisation of a new human bladder cancer cell line, UCRU-BL-28. J Urol 150: 1038-1044, 1993. (Pubitemid 23241331)
19. Masters JR, Hepburn JR, Walker L, et al: Tissue culture model of transitional cell carcinoma: characterisation of twenty-two human urothelial cell lines. Cancer Res 46: 3630-3636, 1986. (Pubitemid 16096920)
20. Russell PJ, Jelbart M, Wills E, Singh S, Wass J, Wotherspoon J and Raghavan D: Establishment and characterisation of a new human bladder cancer cell line showing features of squamous and glandular differentiation. Int J Cancer 41: 74-82, 1988. (Pubitemid 18049353)
21. Brown JL, Russell PJ, Philips J, Wotherspoon J and Ragahavan D: Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br J Cancer 61: 369-376, 1990. (Pubitemid 20106007)
22. Katoh M: Strabismus (STB)/Vang-like (VANGL) gene family. Int J Mol Med 10: 11-15, 2002.
23. Torban E, Kor C and Gros P: Van Gogh-like2 (Strabismus) and its role in planar cell polarity and convergent extension in vertebrates. Trends Genet 20: 570-577, 2004. (Pubitemid 39314565)
24. Phillips KK, White AE, Hicks DJ, Welch DR, Barrett JC, Wei LL and Weissman BE: Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Molec Carcinogen 21: 111-120, 1998. (Pubitemid 28122846)
25. Zhou B, Liu L, Reddivari M and Zhang XA: The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Cancer Res 64: 7455-7463, 2004. (Pubitemid 39372088)